Market Fraud Suits Should Be Covered, Pharma Co. Says

A pharmaceutical company told a Delaware federal court that several lawsuits brought against it by stockholders following a subpoena and investigation by the U.S. Securities and Exchange Commission should be deemed...

Already a subscriber? Click here to view full article